Impact of febrile neutropenia and colony stimulating factor use on chemotherapy delivery in patients with lymphoma: Results from the INC-EU prospective observational European neutropenia study.

被引：0
|
作者：
Pettengell, Ruth
Bosly, Andre
Szucs, Thomas D.
Jackisch, Christian
Leonard, Robert
Paridaens, Robert
Constenla, Manuel
Schwenkglenks, Matthias
机构：
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.2444.2444
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2444
引用
收藏
页码：692A / 692A
页数：1
相关论文
共 50 条
  • [1] Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia study
    Ruth Pettengell
    Matthias Schwenkglenks
    Robert Leonard
    André Bosly
    Robert Paridaens
    Manuel Constenla
    Thomas D. Szucs
    Christian Jackisch
    Supportive Care in Cancer, 2008, 16 : 1299 - 1309
  • [2] Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia study
    Pettengell, Ruth
    Schwenkglenks, Matthias
    Leonard, Robert
    Bosly, Andre
    Paridaens, Robert
    Constenla, Manuel
    Szucs, Thomas D.
    Jackisch, Christian
    SUPPORTIVE CARE IN CANCER, 2008, 16 (11) : 1299 - 1309
  • [3] Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia Study
    Pettengell, Ruth
    Bosly, Andre
    Szucs, Thomas D.
    Jackisch, Christian
    Leonard, Robert
    Paridaens, Robert
    Constenla, Manuel
    Schwenkglenks, Matthias
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 144 (05) : 677 - 685
  • [4] INC-EU Prospective Observational European Neutropenia Study: preliminary breast cancer results
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 95 - 95
  • [5] INC-EU prospective observational European neutropenia study: Design and current status
    BREAST, 2005, 14 : S36 - S36
  • [6] Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia Study
    Matthias Schwenkglenks
    Ruth Pettengell
    Christian Jackisch
    Robert Paridaens
    Manuel Constenla
    André Bosly
    Thomas D. Szucs
    Robert Leonard
    Supportive Care in Cancer, 2011, 19 : 483 - 490
  • [7] Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia Study
    Schwenkglenks, Matthias
    Pettengell, Ruth
    Jackisch, Christian
    Paridaens, Robert
    Constenla, Manuel
    Bosly, Andre
    Szucs, Thomas D.
    Leonard, Robert
    SUPPORTIVE CARE IN CANCER, 2011, 19 (04) : 483 - 490
  • [8] The reliability of FEbrile Neutropenia after ChEmotherapy (FENCE) scores in predicting granulocyte colony-stimulating factor breakthrough febrile neutropenia among patients with lymphoma undergoing first-cycle chemotherapy: A prospective observational study
    Thungthong, Pravinwan
    Chamnanchanunt, Supat
    Suwanban, Tawatchai
    Nakhahes, Chajchawan
    Iam-Arunthai, Kunapa
    Akrawikrai, Tananchai
    Bunworasate, Udomsak
    Rojnuckarin, Ponlapat
    FRONTIERS IN MEDICINE, 2023, 10
  • [9] Incidence of febrile neutropenia, chemotherapy delivery and use of colony-stimulating factor in NHL patients of different age groups
    Pettengell, R.
    Constenla, M.
    Schwenkglenks, M.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 72 : S45 - S46
  • [10] IMPACT OF FEBRILE NEUTROPENIA ON RCHOP CHEMOTHERAPY DELIVERY AND HOSPITALIZATIONS: RESULTS FROM AN INTERNATIONAL OBSERVATIONAL STUDY IN PATIENTS WITH NON-HODGKIN LYMPHOMA (IMPACT NHL)
    Pettengell, R.
    Johnsen, H. E.
    Lugtenburg, P.
    Salar, A.
    Duehrsen, U.
    Haioun, C.
    Verhoef, G.
    Rossi, F.
    Schwenkglenks, M.
    Bendall, K.
    Szabo, Z.
    Jaeger, U.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 365 - 365
12345